D.E. Shaw & Co
CARL

D.E. Shaw & Co’s Carlsmed CARL Stock Holding History

D.E. Shaw & Co’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,037
Closed -$134K – 5121
2025
Q3 		$134K Buy
+10,037
New +$137K ﹤0.01% 4332

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's CARL Position: Q4 2025 in Review

D.E. Shaw & Co sold out of Carlsmed (CARL) in Q4 2025, closing a stake of 10,037 shares — an estimated $134K sold.

D.E. Shaw & Co first reported a position in CARL in Q3 2025 and held it in 1 quarter. The position peaked at $134K in Q3 2025. 57 funds tracked by Wall St. Rank hold CARL as of Q4 2025.

  • D.E. Shaw & Co reported no remaining Carlsmed position as of Q4 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,037 Carlsmed shares in Q4 2025, an estimated $134K.
  • D.E. Shaw & Co first reported a position in Carlsmed in Q3 2025 and held it in 1 quarter.
  • D.E. Shaw & Co's Carlsmed position peaked at $134K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Carlsmed as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.